ALX Oncology Holdings ALXO

$ 1.41 8.91%

Quarterly report 2024-Q3
added 11-07-2024

ALX Oncology Holdings Financial Statements 2011-2024 | ALXO

Annual Financial Statements ALX Oncology Holdings

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	698 M	241 M	866 M	1.59 B	-	-	-	-	-	-	-	-	-
Shares	43 M	40.7 M	40.3 M	18.5 M	-	-	-	-	-	-	-	-	-
Historical Prices	16.2	5.92	21.5	86.2	-	-	-	-	-	-	-	-	-
Net Income	-161 M	-123 M	-83.5 M	-45.7 M	-19.2 M	-13.7 M	-	-	-	-	-	-	-
Revenue	-	-	-	1.18 M	4.8 M	2.07 M	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	436 K	187 K	-	-	-	-	-	-	-
Operating Income	-170 M	-127 M	-83.6 M	-43.7 M	-19.2 M	-13.7 M	-	-	-	-	-	-	-
Interest Expense	1.56 M	238 K	13 K	-1.34 M	-5 K	-	-	-	-	-	-	-	-
EBITDA	-169 M	-127 M	-83.5 M	-43.5 M	-18.8 M	-13.3 M	-	-	-	-	-	-	-
Operating Expenses	170 M	127 M	83.6 M	44.8 M	19.6 M	13.9 M	-	-	-	-	-	-	-
General and Administrative Expenses	28.5 M	29 M	23.4 M	14.8 M	3.31 M	2.6 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement ALX Oncology Holdings

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	52.7 M	51.8 M	50.1 M	50 M	41.1 M	40.9 M	40.9 M	40.9 M	40.7 M	40.7 M	40.6 M	40.6 M	40.4 M	40.2 M	40.1 M	39.8 M	29.7 M	3.16 M	3.14 M	3.17 M	3.1 M	3.09 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-30.7 M	-39.4 M	-35.6 M	-	-51 M	-34.2 M	-30.2 M	-	-35.3 M	-32.9 M	-24.5 M	-	-24.6 M	-16.3 M	-14.2 M	-18.8 M	-10.2 M	-11.3 M	-5.45 M	-8.84 M	-3.04 M	-4.2 M	-4.24 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.18 M	527 K	655 K	-	1.26 M	1.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-32.6 M	-41.5 M	-37.8 M	-	-53.3 M	-36.8 M	-32.2 M	-	-36.7 M	-33.8 M	-24.7 M	-	-24.6 M	-16.3 M	-14.2 M	-	-9.81 M	-10.8 M	-5.24 M	-	-3.03 M	-4.19 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	446 K	429 K	427 K	-	391 K	372 K	387 K	-	2 K	2 K	3 K	-	-12 K	2 K	-2 K	-	-111 K	-305 K	7 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-32.4 M	-41.3 M	-37.5 M	-	-53.1 M	-36.6 M	-32 M	-	-36.6 M	-33.7 M	-24.7 M	-	-24.6 M	-16.3 M	-14.2 M	-	-9.61 M	-10.6 M	-5.13 M	-	-2.72 M	-3.98 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	32.6 M	41.5 M	37.8 M	-	53.3 M	36.8 M	32.2 M	-	36.7 M	33.8 M	24.7 M	-	24.6 M	16.3 M	14.2 M	17.8 M	9.81 M	11.3 M	5.9 M	8.95 M	4.29 M	5.48 M	5.26 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	6.1 M	6.87 M	6.04 M	-	7.51 M	7.3 M	7.44 M	-	7.3 M	7.04 M	7.67 M	-	6.36 M	5.09 M	4.36 M	-	4.48 M	3.17 M	1.47 M	-	938 K	679 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency